NCT04361227

Brief Summary

This study is a prospective study where the investigators will make a database of all the patients who have received this procedure and will document various outcomes (i.e. number of sutures used, number of clips (if used), time required to close, complications/ issues). No changes will be done to the participant's procedure and the participants are asked to consent for the use of the participant's data in our database. The participants are being asked to be in this research study because the participants have been scheduled to undergo an ESD procedure at Baylor St. Luke Medical Center and will most likely require clipping and/or suturing following intervention. This study is important because this is a relatively new procedure; although it is a part of the participant's standard of care, it is not done in many hospitals. The investigators would like to document the outcomes and results of such procedures to continuously improve our standard of care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 24, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

July 2, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2022

Completed
Last Updated

February 15, 2023

Status Verified

February 1, 2023

Enrollment Period

1.9 years

First QC Date

April 22, 2020

Last Update Submit

February 13, 2023

Conditions

Keywords

Gastrointestinal NeoplasmsOverStitch SxEndoscopic Submucosal Dissection

Outcome Measures

Primary Outcomes (3)

  • Clinical/technical success rate utilizing endosuture

    To assess feasibility and technical success of using Overstitch Sx system for closure after ESD

    2 years

  • Rate of patients reported with bleeding/perforation post-ESD procedure

    Conduct follow-ups for risk of bleeding and perforation after closure

    2 years

  • Closure time after ESD

    Record time needed to close lesion

    2 years

Secondary Outcomes (2)

  • Additional clip closure

    2 years

  • Clips used post-ESD

    2 years

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients referred to/scheduled for ESD procedure at Baylor College of Medicine with possible mucosal defect closure.

You may qualify if:

  • Adults age 18-99, who are scheduled to undergo ESD procedure with possible mucosal defect closure.

You may not qualify if:

  • Age is less than 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

Related Publications (1)

  • Keihanian T, Zabad N, Khalaf M, Abdel-Jaber W, Kim YI, Jawaid SA, Abidi WM, Marginean EC, Othman MO. Safety and efficacy of a novel suturing device for closure of large defects after endoscopic submucosal dissection (with video). Gastrointest Endosc. 2023 Sep;98(3):381-391. doi: 10.1016/j.gie.2023.04.006. Epub 2023 Apr 14.

Biospecimen

Retention: SAMPLES WITH DNA

Gastrointestinal lesion/biopsy for pathological evaluation

MeSH Terms

Conditions

Gastrointestinal Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
48 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 22, 2020

First Posted

April 24, 2020

Study Start

July 2, 2020

Primary Completion

May 31, 2022

Study Completion

October 20, 2022

Last Updated

February 15, 2023

Record last verified: 2023-02

Locations